drugset / Trial / NCT00984516
Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study was to investigate the scar-improvement efficacy of three doses of intradermal Juvidex given once only or three times in male and female subjects and to collect further safety and tolerability data for intradermal Juvidex in male and female subjects.
Timeline
- Start
- 2004-08
- Primary completion
- 2006-01
- Completion
- 2006-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Juvidex | Unknown | 2.82 mg | Other |
| Subject | Juvidex | Unknown | 5.64 mg | Other |
| Subject | Juvidex | Unknown | 11.28 mg | Other |
Indications
No indication recorded.